What was filed
Fermenta Biotech Limited has told the exchanges, under Regulation 29 of SEBI's Listing Obligations and Disclosure Requirements, that its board of directors will meet on Tuesday, 11 August 2026 to consider and approve the unaudited standalone and consolidated financial results for the quarter ended 30 June 2026.
The intimation is procedural and carries no financial figures; those follow when the board meets.
Trading window
The company confirmed that its trading window has been closed with effect from 1 July 2026, under its insider-trading code, and will stay shut until 48 hours after the results are declared. Through this period, directors, promoters, designated persons and other connected persons are barred from dealing in the company's shares.